Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.3
Power Rank trend -> Rising
Industry: Medical Devices
Follow @stockchartsai on TwitterIn the past 20 trading days, STE has been trading in a range between $240.53 and $229.77 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
STE is trading below resistance at $242.60, about 1% to the upside. There is support at $232.77 -3% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
STERIS plc $STE entered a Green zone 10 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $242, a potential upside of 0.91% from the recent price of 239.82. The stock is trading 2.26% (potential upside) below its 52 week high of $245.23 and 23.54 % (potential downside) above its 52 week low of $194.12 - based on the recent price.
STERIS plc provides infection prevention products and services worldwide It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue? Steris (STE) reported earnings 30 days ago. What's next for the stock? Source: Zacks Investment Research Thu, 05 Sep 2024 12:35:53 -0400 Sentiment: Positive |
Reasons to Retain STERIS Stock in Your Portfolio for Now STE's strong prospects in the healthcare business arm bode well for investors. Source: Zacks Investment Research Wed, 04 Sep 2024 09:35:54 -0400 Sentiment: Positive |
15 Upcoming Dividend Increases Including A King This week, 15 companies, including Dividend King Stanley Black & Decker, are set to increase dividends, with SWK extending its 57-year streak by 1.2%. My strategy focuses on buying, holding, and adding companies that consistently increase dividends and outperform benchmarks, using SCHD as a performance gauge. The list of dividend increases is curated by merging data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, emphasizing companies with at least five years of dividend growth. Source: Seeking Alpha Thu, 29 Aug 2024 16:51:26 -0400 Sentiment: Positive |
STERIS to Present at the Morgan Stanley Healthcare Conference DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024. Dan Carestio, President and CEO of STERIS will present at 1:50 p.m. Eastern Time. Source: GlobeNewsWire Mon, 26 Aug 2024 16:30:00 -0400 Sentiment: Neutral |
Steris: Q2 Numbers Solidify Buy Thesis STE's Q1 FY'25 numbers were in line with expectations, with upsides in the healthcare and AST divisions. The company shows consistent free cash flow production and stable earnings on its capital base. I've revised our estimate on the intrinsic worth of the business to $270 per share, reiterating a buy. Source: Seeking Alpha Tue, 13 Aug 2024 09:51:55 -0400 Sentiment: Positive |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.